Reading time: 7 minutes Lubna Najm Ovarian cancer is one of the top ten most common malignancies to affect women and females worldwide (NIH National Cancer Institute, 2025; Wang et al., 2025), with a 51.6% five-year survival rate (NIH National Cancer Institute, 2025). Named the ‘silent killer’ amongst women-prevalent diseases because its symptoms are either... Continue Reading →
Reading time: 8 minutes Alex DeWalle At the core of translational oncology lies a fundamental problem: how do we kill tumor cells without harming healthy tissue? Novel therapies must directly target tumor cells to achieve this goal in a way that traditional chemotherapies cannot. CAR T-cell therapy (CAR T) is one of the most promising... Continue Reading →
Taylor B. Poston Chlamydia is the most common sexually transmitted bacterial infection in the world, and 75% of infected women never develop symptoms. Furthermore, chlamydia will ascend from the cervix to the upper genital tract in 40% of infected women. This infection of the endometrium puts women at risk for pelvic inflammatory disease and infertility.... Continue Reading →
Sara Musetti Historians love to say that those who do not know their history are doomed to repeat it. In science, failing to remember and understand our history means that we may need to make the same discoveries again and again. This appears to be the case for cancer immunotherapy, a new branch of research... Continue Reading →
OncoBites 